Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry

Nodular melanoma (NM) is associated with a higher locoregional and distant recurrence rate compared with superficial spreading melanoma (SSM); it is unknown whether the efficacy of systemic therapy is limited. Here, we compare the efficacy of immunotherapy and BRAF/MEK inhibitors (BRAF/MEKi) in advanced NM to SSM. Patients with advanced stage IIIc and stage IV NM and SSM treated with anti-CTLA-4 and/or anti-PD-1, or BRAF/MEKi in the first line, were included from the prospective Dutch Melanoma Treatment Registry. The primary objectives were distant metastasis-free survival (DMFS) and overall s... Mehr ...

Verfasser: Daan Jan Willem Rauwerdink
Remco van Doorn
Jos van der Hage
Alfonsus J. M. Van den Eertwegh
John B. A. G. Haanen
Maureen Aarts
Franchette Berkmortel
Christian U. Blank
Marye J. Boers-Sonderen
Jan Willem B. De Groot
Geke A. P. Hospers
Melissa de Meza
Djura Piersma
Rozemarijn S. Van Rijn
Marion Stevense
Astrid Van der Veldt
Gerard Vreugdenhil
Michel W. J. M. Wouters
Karijn Suijkerbuijk
Monique van der Kooij
Ellen Kapiteijn
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Cancers, Vol 14, Iss 5694, p 5694 (2022)
Verlag/Hrsg.: MDPI AG
Schlagwörter: melanoma / immune checkpoint inhibitors / targeted therapy / survival / Neoplasms. Tumors. Oncology. Including cancer and carcinogens / RC254-282
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26625687
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/cancers14225694